Health Catalyst, Inc. (HCAT)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Health Catalyst, Inc. (HCAT) operates in the Healthcare sector, last quoted at $1.10 with a $80.94M market capitalization. The stock scores 52/100, a moderate rating based on 9 quantitative KPIs.
Last analyzed: 2026年2月9日Health Catalyst, Inc. (HCAT) Healthcare & Pipeline Overview
Health Catalyst empowers healthcare organizations with cutting-edge data and analytics solutions, driving improved patient outcomes and financial performance. With a comprehensive platform and specialized services, HCAT is positioned to capitalize on the growing demand for data-driven healthcare transformation, despite current profitability challenges.
Investment Thesis
Health Catalyst presents a notable research candidate within the healthcare analytics space, driven by the increasing demand for data-driven decision-making in healthcare. While the company currently operates with a negative P/E ratio of -1.41 and a negative profit margin of -34.1%, its strong gross margin of 46.5% indicates potential for future profitability as it scales its operations and achieves greater efficiency. Key growth catalysts include the expansion of its AI and data science offerings and the increasing adoption of its population health management solutions. The company's focus on providing actionable insights and automated workflows positions it to capture a significant share of the growing healthcare analytics market. Investors should monitor the company's progress in improving its financial performance and achieving profitability, with a focus on revenue growth and cost management. The company's high beta of 1.74 suggests higher volatility compared to the market.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap of $0.15B reflects its position as a smaller player in the healthcare analytics market, offering potential for growth.
- Gross Margin of 46.5% demonstrates the value of its data and analytics platform and services.
- P/E Ratio of -1.41 indicates that the company is currently not profitable, requiring careful monitoring of its financial performance.
- Beta of 1.74 suggests higher volatility compared to the market, which could lead to larger gains or losses.
- No Dividend Yield reflects the company's focus on reinvesting earnings to fund growth initiatives.
Competitors & Peers
Strengths
- Comprehensive data and analytics platform for healthcare.
- Strong expertise in healthcare data and analytics.
- Established relationships with healthcare organizations.
- National data ecosystem for knowledge sharing.
Weaknesses
- Currently unprofitable with a negative profit margin.
- High beta indicates higher volatility.
- Smaller market capitalization compared to larger competitors.
- Reliance on subscription and service revenue.
Catalysts
- Upcoming: Expansion of AI-powered analytics capabilities to enhance clinical decision support.
- Ongoing: Increasing adoption of the Health Catalyst data platform by healthcare systems seeking improved data insights.
- Ongoing: Strategic partnerships with healthcare providers to implement population health management programs.
- Upcoming: Launch of new data products and services to address emerging needs in the healthcare industry.
Risks
- Potential: Intense competition from larger, more established healthcare analytics providers.
- Ongoing: The company's current unprofitability and negative profit margin pose a risk to its long-term sustainability.
- Potential: Evolving regulatory landscape for healthcare data privacy could impact data collection and usage.
- Potential: Economic downturn impacting healthcare spending could reduce demand for Health Catalyst's solutions.
Growth Opportunities
- Expansion of AI and Data Science Offerings: Health Catalyst can capitalize on the increasing demand for AI-powered analytics in healthcare by expanding its AI and data science offerings. This includes developing new AI algorithms and models for predictive analytics, personalized medicine, and clinical decision support. The market for AI in healthcare is projected to reach $34 billion by 2025, presenting a significant growth opportunity for Health Catalyst. Timeline: Ongoing.
- Increased Adoption of Population Health Management Solutions: Health Catalyst can drive growth by increasing the adoption of its population health management solutions. This includes expanding its partnerships with healthcare providers and payers to implement programs that improve patient outcomes and reduce costs. The market for population health management is expected to reach $89 billion by 2027, offering a substantial growth opportunity. Timeline: Ongoing.
- Strategic Partnerships and Acquisitions: Health Catalyst can accelerate its growth through strategic partnerships and acquisitions. This includes partnering with other healthcare technology companies to expand its product offerings and reach new markets. It can also acquire companies with complementary technologies or customer bases. Timeline: Ongoing.
- Expansion into New Geographies: Health Catalyst can expand its geographic reach by entering new markets, both domestically and internationally. This includes targeting healthcare organizations in regions with high growth potential and limited access to advanced analytics solutions. Timeline: Ongoing.
- Development of New Data Products and Services: Health Catalyst can drive growth by developing new data products and services that address emerging needs in the healthcare industry. This includes creating data marketplaces, providing data governance solutions, and offering data science consulting services. Timeline: Ongoing.
Opportunities
- Expansion of AI and data science offerings.
- Increased adoption of population health management solutions.
- Strategic partnerships and acquisitions.
- Expansion into new geographies.
Threats
- Intense competition from larger healthcare analytics providers.
- Evolving regulatory landscape for healthcare data privacy.
- Potential for data breaches and security vulnerabilities.
- Economic downturn impacting healthcare spending.
Competitive Advantages
- Proprietary data and analytics platform designed specifically for healthcare.
- Deep domain expertise in healthcare data and analytics.
- Established relationships with leading healthcare organizations.
- National data ecosystem for knowledge exchange and collaboration.
About HCAT
Health Catalyst, Inc., founded in 2008 and headquartered in South Jordan, Utah, is a leading provider of data and analytics technology and services to healthcare organizations. Originally known as HQC Holdings, Inc., the company rebranded to Health Catalyst in March 2017, reflecting its focus on catalyzing healthcare transformation through data. The company's core offering is its data and analytics platform, a commercial-grade solution designed specifically for the healthcare sector. This platform integrates with various healthcare systems to collect, process, and analyze data, providing insights that drive improvements in clinical, financial, and operational performance. Health Catalyst also offers AI and data science solutions, enabling healthcare organizations to leverage advanced analytics to improve accuracy and efficiency. Their services extend to population health management, financial transformation, and quality and safety improvement, providing healthcare providers with actionable guidance and automated workflows. Health Catalyst's national data ecosystem facilitates knowledge exchange and collaboration among healthcare organizations, fostering innovation and best practices. Despite its innovative solutions, Health Catalyst faces challenges in achieving profitability, as reflected in its negative profit margin.
What They Do
- Provides a data and analytics platform for healthcare organizations.
- Offers AI and data science solutions to improve analytics accuracy.
- Delivers population health management tools for care continuum improvement.
- Provides financial transformation insights for costing, labor productivity, and revenue capture.
- Offers quality and safety improvement solutions using clinical data.
- Facilitates a national data ecosystem for knowledge exchange.
Business Model
- Subscription-based revenue for access to its data and analytics platform.
- Professional services fees for implementation, consulting, and training.
- Revenue from AI and data science solutions.
- Revenue from population health management services.
Industry Context
Health Catalyst operates in the rapidly evolving healthcare information services industry, which is driven by the increasing adoption of electronic health records (EHRs), the growing demand for value-based care, and the need to improve patient outcomes and reduce costs. The market for healthcare analytics is expected to grow significantly in the coming years, driven by the increasing availability of data and the development of advanced analytics technologies. Health Catalyst competes with other healthcare analytics providers, including Cerner (now Oracle), Allscripts, and smaller, more specialized players. The company differentiates itself through its focus on providing actionable insights and automated workflows, as well as its national data ecosystem for knowledge exchange.
Key Customers
- Hospitals and health systems.
- Physician groups and clinics.
- Accountable care organizations (ACOs).
- Health insurance payers.
Financials
Chart & Info
Health Catalyst, Inc. (HCAT) stock price: $1.10 (+0.00, +0.00%)
Latest News
-
12 Health Care Stocks Moving In Friday's Intraday Session
benzinga · 2026年3月13日
-
12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga · 2026年3月12日
-
Earnings Scheduled For March 12, 2026
benzinga · 2026年3月12日
-
3 Cash-Burning Stocks Walking a Fine Line
StockStory · 2026年2月12日
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for HCAT.
Price Targets
Wall Street price target analysis for HCAT.
MoonshotScore
What does this score mean?
The MoonshotScore rates HCAT's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Common Questions About HCAT
What are the key factors to evaluate for HCAT?
Health Catalyst, Inc. (HCAT) currently holds an AI score of 52/100, indicating moderate score. Key strength: Comprehensive data and analytics platform for healthcare. Primary risk to monitor: Intense competition from larger, more established healthcare analytics providers. This is not financial advice.
How frequently does HCAT data refresh on this page?
HCAT prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven HCAT's recent stock price performance?
Recent price movement in Health Catalyst, Inc. (HCAT) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Comprehensive data and analytics platform for healthcare.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider HCAT overvalued or undervalued right now?
Determining whether Health Catalyst, Inc. (HCAT) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying HCAT?
Before investing in Health Catalyst, Inc. (HCAT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding HCAT to a portfolio?
Potential reasons to consider Health Catalyst, Inc. (HCAT) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Comprehensive data and analytics platform for healthcare.. Additionally: Strong expertise in healthcare data and analytics.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of HCAT?
Yes, most major brokerages offer fractional shares of Health Catalyst, Inc. (HCAT) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track HCAT's earnings and financial reports?
Health Catalyst, Inc. (HCAT) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for HCAT earnings announcements is recommended.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Stock data pending update, limiting complete financial analysis.